- Anticancer agent 3-bromopyruvic acid forms a conjugate with glutathione
Izabela Sadowska-Bartosz et al, 2016, Pharmacological Reports CrossRef - Impaired mitochondrial functions contribute to 3-bromopyruvate toxicity in primary rat and mouse hepatocytes
Ondřej Sobotka et al, 2016, Journal of Bioenergetics and Biomembranes CrossRef - Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer
Hsin-Chih Yeh et al, 2022, European Journal of Pharmacology CrossRef - The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
Li Yu et al, 2016, Oncotarget CrossRef - 3-Bromopyruvate induces expression of antioxidant genes
Lukasz Pulaski et al, 2019, Free Radical Research CrossRef - Influence of high glucose state on bromopyruvate-induced cytotoxity by human colon cancer cell lines
Masaya Ideno et al, 2016, Drug Metabolism and Pharmacokinetics CrossRef - NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells
Jiajia Hu et al, 2015, Scientific Reports CrossRef - Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice
Qiong Pan et al, 2016, Acta Cirurgica Brasileira CrossRef - Mitochondrial-targeted penetrating peptide delivery for cancer therapy
Jiao Wu et al, 2018, Expert Opinion on Drug Delivery CrossRef - Multimodal Imaging of Pancreatic Cancer Microenvironment in Response to an Antiglycolytic Drug
Elnaz Sheikh et al, 2023, Advanced Healthcare Materials CrossRef - Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma
Raquel G. Coelho et al, 2015, Oncotarget CrossRef